Global Prostate-specific Antigen (PSA) Testing Market Size, Status and Forecast 2020-2026

Prostate-specific antigen (PSA) is a protein secreted only by epithelial prostate cells, and its elevation in serum is used to detect prostate cancer in men.Elevated PSA levels are associated with prostatitis, inflammation of the prostate or benign forms of prostatic hyperplasia, making it a valuable tumor marker for prostate cancer.The use of serology-based biomarkers for the diagnosis of prostate cancer has stimulated the need for prostate-specific antigen (PSA).
Market Analysis and Insights: Global Prostate-specific Antigen (PSA) Testing Market
In 2019, the global Prostate-specific Antigen (PSA) Testing market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Prostate-specific Antigen (PSA) Testing Scope and Market Size
Prostate-specific Antigen (PSA) Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate-specific Antigen (PSA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Prostate-specific Antigen (PSA) Testing market is segmented into CLIA Method, ELISA Method, etc.
Segment by Application, the Prostate-specific Antigen (PSA) Testing market is segmented into Screening, Post-treatment Monitoring, Other, etc.
Regional and Country-level Analysis
The Prostate-specific Antigen (PSA) Testing market is analysed and market size information is provided by regions (countries).
The key regions covered in the Prostate-specific Antigen (PSA) Testing market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Prostate-specific Antigen (PSA) Testing Market Share Analysis
Prostate-specific Antigen (PSA) Testing market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Prostate-specific Antigen (PSA) Testing business, the date to enter into the Prostate-specific Antigen (PSA) Testing market, Prostate-specific Antigen (PSA) Testing product introduction, recent developments, etc.
The major vendors include Abbott, Boston Scientific Corporation, Bayer AG, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical, Fujirebio, Mediwatch, BodiTech, Bristol-Myers Squibb Company, GE Healthcare, Endocare, Merck＆Co., Medtronic, Sanofi-Aventis SA, etc.

This report focuses on the global Prostate-specific Antigen (PSA) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate-specific Antigen (PSA) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA

Market segment by Type, the product can be split into

CLIA Method
ELISA Method

Market segment by Application, split into

Screening
Post-treatment Monitoring
Other

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Prostate-specific Antigen (PSA) Testing status, future forecast, growth opportunity, key market and key players.
To present the Prostate-specific Antigen (PSA) Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Prostate-specific Antigen (PSA) Testing are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.